The University of Iowa

State Hygienic Laboratory

Breadcrumb

  1. Home
  2. Testing Specialties
  3. Diagnostic and Clinical Testing

Test Detail


Influenza SARS-CoV-2 (Flu SC2) Multiplex

Back to Test Directory
Test Description
  • Contact: Molecular Biology and Virology (319) 335-4376
  • Test Request Form: COVID-19/Flu Electronic Test Request Form. This electronic form is part of the OpenELIS Web Portal.
  • SHL OpenELIS Code: 1011
Nucleic acid amplification by PCR to detect Influenza A and B virus RNA and SARS-CoV-2 RNA.
Panel Components
Influenza A RNA, Influenza B RNA, SARS-CoV-2 RNA
Reflex Test(s)
Influenza A Subtype by Polymerase Chain Reaction (PCR), (SARS-CoV-2 by Next Generation Sequencing: results not reported to facility but will be reported to Iowa HHS and CDC.)
Performed Avg. Turnaround Time Method
Coralville, 8 a.m. - 5 p.m., M-F
1 - 5 business days Nucleic Acid Amplification by Real-Time Polymerase Chain Reaction (PCR)
Fee CPT Code(s)
No charge. 87798
Specimen Requirements
Specimen Type: Nasopharyngeal (NP) swab, Pooled Nasopharyngeal and Oropharyngeal swab, Throat swab, Nasal swab, Sputum, Tracheal aspirate, Bronchoalveolar lavage fluid (BAL), Bronchial brushings sample, Nasopharyngeal (NP) washings/aspirate, or Nasal wash/aspirate collected by a healthcare provider. PCR is a very sensitive test, and precautions should be taken to not cross-contaminate specimens (i.e., wear gloves and change before and after collecting specimen. Avoid contact with environmental surfaces). DO NOT FREEZE SPECIMEN.
Collection Kits: Collect specimen using a SHL Virus Isolation and Detection Kit (contains M4-RT viral transport medium and swabs) or equivalent viral transport medium. Order Virus Isolation and Detection Kit at http://www.shl.uiowa.edu/kitsquotesforms/clinicalkit.xml.

Collection instructions for upper and lower respiratory tract specimens are available on the CDC website at https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html.
Collection Instructions: Nasopharyngeal (NP) Swab: A nasopharyngeal (NP) swab placed into viral transport medium (VTM) is the preferred choice for swab-based SARS-CoV-2 testing. To date, the scientific literature states that nasopharyngeal specimens have the highest yield of recovery of an infected patient. Insert swab through the nostril into the nasopharynx until tip reaches the posterior nasopharynx (a distance equivalent to that from the ear to the nostril of the patient). Leave the swab in place for 10 - 30 seconds. Slowly remove with a rotating motion. Place swab in M4-RT transport medium.
    Combination Swabs: Nasal - Place Dacron-tipped or flocked swab in each nostril and allow to remain in place for several seconds. Place the swabs in tube containing M4-RT transport medium. Throat - Rub the tonsils and posterior pharynx with Dacron-tipped or flocked swab. Place the swabs in tube containing M4-RT transport medium.
      Upper respiratory: Oropharyngeal (OP) specimen, Anterior nares specimen (using a round foam swab), Nasopharyngeal wash (collect 2 - 3 mL into a sterile, leak-proof, screw cap container).
        Lower respiratory: Collect 2 - 3 mL into a sterile, leak-proof, screw-cap container. Sputum specimens are acceptable for patients with a productive cough (Do not induce sputum collection), Bronchoalveolar lavage (BAL), Bronchial wash, Endotracheal aspirate.
          Acceptable Swabs: Synthetic tips (e.g. polyester or dacron) with a flexible plastic shaft, Eswab, Flocked swabs.
            Shipping:
            Specimens should be stored and shipped under the same conditions. Wrap specimen container in absorbent material and place inside a biohazard bag. Transport specimen with cold pack. Ship to the Coralville location.
            Temperature and Stability: Refrigerated (2-8 degrees C); stable for 72 hours.
            Rejection Criteria: Specimens will be rejected if received under these conditions:

            Frozen samples; Sample obtained on cotton-tipped, wooden- or aluminum-shafted or calcium alginate swabs; Swabs submitted in bacterial transport media (usually clear fluid); Broken, leaking, or unlabeled sample containers; Samples containing swabs other than those provided in the collection kit. Specimens not received in the correct temperature ranges stated under "Temperature and Stability" will be rejected.
            Expected Results:
            Influenza A RNA Detected, Influenza B RNA Detected, SARS-CoV-2 RNA Detected, Not Detected, Invalid
            Comments
            Negative Flu SC2 Multiplex Assay results do not preclude SARS-CoV-2, influenza A, and/or influenza B infection and should not be used as the sole basis for diagnosis, treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information.
            Alternate Names
            Influenza, Influenza A and B, Influenza PCR, SARS-CoV-2 PCR, COVID-19 PCR, 2019 Novel Coronavirus PCR
            The University of Iowa

            State Hygienic Laboratory

            General inquires
            SHL Client Services
            319-335-4500 or 1-800-421-IOWA (4692)
            ask-shl@uiowa.edu

            Footer primary

            • HIPAA Notice of Privacy Practice
            • Copyright 2025 The University of Iowa
            • Privacy Notice
            • UI Nondiscrimination Statement
            • Accessibility